The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tamoxifen versus aromatase inhibitors for the adjuvant treatment of breast cancer in older women: A feasibility study to examine differences in cognitive outcomes.
 
Emily Anne Underwood
No Relationships to Disclose
 
Katarzyna Joanna Jerzak
No Relationships to Disclose
 
Kathleen I. Pritchard
Honoraria - Amgen; AstraZeneca; Eisai; GlaxoSmithKline; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Eisai; GlaxoSmithKline; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Eisai; GlaxoSmithKline; Novartis; Pfizer; Roche
 
Mary Catherine Tierney
No Relationships to Disclose